The race to remake treatment of the world's most common mental health problem
STAT's latest 40 page report on depression treatment details the challenges, possibilities and frontrunners in the race to develop precise and effective drugs for the world's most common mental health problem. Written by Ben Carey, former human behavior reporter for The New York Times.
This report is meant for anyone with a strong interest in depression treatment, including scientists, investors, drug developers, doctors and regulators, and for those who have been around the block with antidepressants and hope for more, for better — who could use some hope, of any kind.
In this report you will discover:
- Learn about the five families of compounds under development and the possibilities and pitfalls for companies hoping to bring them to market
- Gain an understanding of the role psychedelics have played in pioneering this new frontier
- Hear how neuroscientists and psychiatrists are changing their thinking about the diagnosis of depression and the best approach to treating patients
GET THE REPORT
About STAT Reports
STAT Reports help business executives, researchers, consultants, and analysts navigate the ever-changing life sciences industry. Each report provides deep analysis of a particular issue in health care. Pick and purchase the reports that are most relevant to you.
LEARN MORE
Other topics include:
No comments